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Tea tree oil (TTO) is an interesting product derived from
Melaleuca alternifolia, a plant species native to Australia
where the oil has been used as a traditional topical med-
ication. A search of the internet reveals that TTO is now
widely available internationally, as a pure oil or as an ingre-
dient of multiple skin care and other over-the-counter prod-
ucts. It is found in soaps, bath additives, shampoos and
conditioners, in topical treatments for bacterial, fungal and
viral infections, head lice, ticks and insect bites, and in in-
sect repellents. It is recommended in commercial adver-
tisements for topical treatment of psoriasis, dermatitis,
plantar warts, sunburn, thermal burns, bruises, other skin
wounds including bedsores, muscular strains, arthritis, and
even for diabetic gangrene. The same website recommends
TTO as an inhalant for asthma, bronchitis and laryngitis, yet
in a section on safety advises removal of the victim to fresh
air and the immediate attention of a physician if it is inhaled.
It is an ingredient of toothpastes and mouthwashes, yet
ingestion of an apparently small quantity of undiluted TTO
by a 4-y-old led to a warning about its potential toxicity in
the face of inadequate safety labels, following an episode of
ataxia and deteriorating consciousness requiring endotra-
cheal intubation (Morris et al, 2003). It is also found in
household products including cleaners and deodorizers,
and its propensity to produce allergic contact dermatitis is
well recognized by dermatologists (Knight and Hausen,
1994). More serious side-effects of topical application
appear to be uncommon, but include immediate systemic
hypersensitivity (Mozelsio et al, 2003).
Clearly, analysis of the identity and properties of the
components of TTO has been an important exercise, and in
the last ten years many interesting reports on this subject
have appeared in the scientific literature. In this issue, Khalil
et al (2004) highlight the complexity of the ingredients of
TTO and study the anti-inflammatory properties of the main
water soluble components, including terpinen-4-ol and 1,8-
cineole. These molecules have a long history, being well
known to terpene chemists. 1,8-Cineole or eucalyptol, also
the chief constituent of eucalyptus oil, is listed in The Merck
Index, which cites reports of its chemical analysis going
back to 1884. The chief component of TTO, terpinen-4-ol, is
widely distributed in plants that vary from oranges and
mandarins, origanum, the New Zealand lemonwood tree
and the Japanese cedar to black pepper. With other terpe-
nes, it is thought to contribute to the unique taste of the
Cuban bullock’s heart fruit (Pino et al, 2003) and it appears
to be an odorant in Muscadet wines (Schneider et al, 2001).
The other biologic properties of terpinen-4-ol, particularly
its role as a biocide, have been quite widely studied. Of
particular interest is its in vitro activity against Staphylococ-
cus aureus, a property that is likely to explain the outcome of
a controlled clinical trial in which TTO was found to be more
effective at clearing superficial skin infection by methicillin-
resistant S. aureus than chlorhexidine or silver sulfadiazine
(Dryden et al, 2004). The described efficacy of terpinen-4-ol
against Propionibacterium acnesmay also explain a positive
therapeutic effect in acne (Bassett et al, 1990). Its biocidal
activity extends to Sarcoptes scabiei, against which it may
have a role as a new acaricide in the face of emerging re-
sistance to existing agents (Walton et al, 2004). With 1,8-
cineole, terpinen-4-ol is also an effective inhibitor of acetyl-
cholinesterase, a property that may explain its insecticidal
effects in the treatment of pediculosis (Mills et al, 2004).
In a recent issue of this journal, Calcabrini et al (2004)
reported that TTO and its main active component, terpinen-
4-ol (at 0.65 mmoles per L), were able to induce
apoptosis of melanoma cells in vitro, particularly in P-glyco-
protein-expressing cells that had acquired drug resistance.
This effect was dependent on caspase activation and pos-
sibly on reorganization of membrane lipids. The authors re-
viewed the evidence that terpenes are able to partition into
phospholipid layers, thereby disrupting hydrophobic struc-
tures. This property may explain the microbicidal activity of
TTO and the ability of terpinen-4-ol to enhance percutane-
ous absorption. The broad effects of this molecule also in-
clude its potential role as an antihypertensive (Lahlou et al,
2003) and as an anti-ulcer agent by virtue of its capacity to
inhibit gastric acid and pepsin output (Matsunaga et al,
2000).
The anti-inflammatory properties of TTO and its compo-
nents are of considerable interest. Some of these proper-
ties, including suppression of superoxide and cytokine
production by stimulated monocytes, and reduction of ed-
ema following provocation of contact hypersensitivity or in-
jection of histamine in mouse ears, have been reported
previously by the co-authors of the paper by Khalil et al
(2004) in this issue. They now report the results of elegant
experiments in a rat footpad model, in which locally applied
1,8-cineole inhibited the microvascular effects of antidromic
nerve stimulation but not the effects of a locally applied
neuropeptide, results that suggest an inhibitory action on
pre-terminal neural events. In contrast, locally applied ter-
pinen-4-ol, unlike 1,8-cineole, inhibited inflammation in-
duced by neuropeptide, especially in sensory-denervated
animals. This suggested a direct effect of terpinen-4-ol on
the cutaneous microvasculature in the rat, independent of
events mediated by sensory nerves. The authors then report
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the ability of topically applied (undiluted) TTO and terpinen-
4-ol, but not 1,8-cineole, to reduce both wheal and flare
reactions induced by intradermal injection of histamine in
human skin. On the basis of the effect of terpinen-4-ol in
their rat model, they suggest that not only the wheal but
also the flare induced by intradermal histamine in human
skin are mediated by direct effects on the microvasculature,
distal to nerve terminals, at least at the dose used (5 mg).
This is a provocative suggestion, as pharmacologists have
long attributed the histamine induced cutaneous flare to
axon reflexes. The authors’ conclusion depends on the va-
lidity of the extrapolation of data derived in their rat model to
human skin, on assumptions about relative rates of percu-
taneous absorption following application of the different
terpenes to human skin, and on the biological effects of
agents that almost certainly lack pharmacologic specificity.
Support for axon reflexes as the mechanism for the wider
flare response following intradermal injection of low nano-
gram amounts of histamine in human skin comes from
careful studies using dermal microdialysis, in which hista-
mine levels were shown to be high at the sites of the wheal,
but close to levels found in uninjected skin in perfusate from
the areas of flare (Clough et al, 1998). There is also the
longstanding human evidence that local anesthetic injection
or application of capsaicin reduces the flare but not the
wheal following intradermal injection of histamine (Foreman
et al, 1983).
The potential of these lipophilic TTO-derived terpenes to
disrupt cellular membranes and consequently their associ-
ated receptors and signal transduction pathways, suggests
a basis for the broad spectrum of effects reviewed above.
On the other hand, the differential actions of terpinen-4-ol
and 1,8-cineole on the cutaneous microvascular effects of
sensory nerve stimulation in the rat, and on histamine-in-
duced responses following topical application to human
skin, as reported by Khalil et al (2004), suggest pharmaco-
logic mechanisms that are more specific. Further work
should clarify the molecular basis of the various effects of
these interesting terpenes in microbial and mammalian
systems.
DOI: 10.1111/j.0022-202X.2004.23451.x
References
Bassett IB, Pannowitz DL, Barnetson RS: A comparative study of tea-tree oil
versus benzoylperoxide in the treatment of acne. Med J Austr 153:455–458,
1990
Calcabrini A, Stringaro A, Toccacieli L, et al: Terpinen-4-ol, the main component
of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human
melanoma cells. J Invest Dermatol 122:349–360, 2004
Clough GF, Bennett AR, Church MK: Effects of H1 antagonists on the cutaneous
vascular reponse to histamine and bradykinin: A study using scanning
laser Doppler imaging. Br J Dermatol 138:806–814, 1998
Dryden MS, Dailly S, Crouch M: A randomized, controlled trial of tea tree topical
preparations versus a standard topical regimen for the clearance of
MRSA colonization. J Hosp Infect 56:283–286, 2004
Foreman JC, Jordan CC, Oehme P, Renner H: Structure–activity relationships for
some substance P-related peptides that cause wheal and flare reactions
in human skin. J Physiol 335:449–465, 1983
Khalil Z, Pearce AL, Satkunanathan N, Storer E, Finlay-Jones JJ, Hart PH: Reg-
ulation of wheal and flare by tea tree oil: Complementary human and
rodent studies. J Invest Dermatol 123:683–690, 2004
Knight TE, Hausen BM: Melaleuca oil (tea tree oil) dermatitis. J Amer Acad
Dermatol 30:423–427, 1994
Lahlou S, Interaminense LF, Leal-Cardoso JH, Duarte GP: Antihypertensive ef-
fects of the essential oil of Alpinia zerumbet and its main constituent,
terpinen-4-ol, in DOCA-salt hypertensive conscious rats. Fund Clin
Pharmacol 17:323–330, 2003
Matsunaga T, Hasegawa C, Kawasuji T, et al: Isolation of the anti-ulcer compound
in essential oil from the leaves of Cryptomeria japonica. Biol Pharm Bull
23:595–598, 2000
Mills C, Cleary BJ, Gilmer JF, Walsh JJ: Inhibition of acetylcholinesterase by Tea
Tree oil. J Pharm Pharmacol 56:375–379, 2004
Morris MC, Donoghue A, Markowitz JA, Osterhoudt KC: Ingestion of tea tree oil
(Melaleuca oil) by a 4-year-old boy. Pediatr Emerg Care 19:169–171, 2003
Mozelsio NB, Harris KE, McGrath KG, Grammer LC: Immediate systemic hyper-
sensitivity reaction associated with topical application of Australian tea
tree oil. Allergy Asthma Proc 24:73–75, 2003
Pino JA, Marbot R, Fuentes V: Characterization of volatiles in bullock’s heart
(Annona reticulata L.) fruit cultivars from Cuba. J Agricult Food Chem
51:3836–3839, 2003
Schneider R, Razungles A, Augier C, Baumes R: Monoterpenic and nor-
isoprenoidic glycoconjugates of Vitis vinifera L. cv. Melon B. as precur-
sors of odorants in Muscadet wines. J Chromatogr 936:145–157, 2001
Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ: Acaricidal
activity of Melaleuca alternifolia (tea tree) oil: In vitro sensitivity of Sarco-
ptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 140:563–566,
2004
THE WIZARD OF OZ xix123 : 4 OCTOBER 2004
